Q2867196 (Q2867196): Difference between revisions
Jump to navigation
Jump to search
(Created a new Item: import item from Portugal) |
(Changed label, description and/or aliases in en: Setting new description) |
||
| description / en | description / en | ||
Project in Portugal | Project Q2867196 in Portugal | ||
Revision as of 22:54, 5 July 2021
Project Q2867196 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q2867196 in Portugal |
Statements
492,223.04 Euro
0 references
76.0 percent
0 references
1 April 2020
0 references
31 December 2020
0 references
LIMM THERAPEUTICS, SOCIEDADE ANÓNIMA
0 references
O projeto apresentado pela LiMM Therapeutics pretende avaliar a possibilidade de desenvolvimento de NRIL01 (reprogramadores neuronais de linfócitos inatos) na presença de SARS-CoV-2, contribuindo desta forma para minimizar as patologias renais como consequência da infeção com este vírus. (Portuguese)
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-02B7-FEDER-069917
0 references